Fetal alcohol syndrome (FAS) occurs in children born to women who drink alcohol heavily during pregnancy and is one of the leading non-hereditary causes of mental retardation in the Western World. It is estimated that the prevalence of FAS in the general U.S. population is between 0.5 and 2.0 per 1,000 births, while the undiagnosed population with variable facial and brain dysmorphology described as fetal alcohol spectrum disorder (FASD) is estimated to be 10 times higher. The difficulty in the diagnosis of FASD involves misdiagnosis due to the presence or absence of the typical facial dysmorphology in association with brain dysfunction. Accurate diagnosis is further complicated by the lack of information about the contribution of dose, frequency, and timing of alcohol exposure during pregnancy to variation in facial dysmorphology. In this project, a mouse model that models human consumption and is known to produce FAS-like features resulting from prenatal alcohol exposure, will be used to test the effects of differences in dose and timing of alcohol exposure on face and brain development. A combination of 3D imaging that includes Micro-video and micro-resonance imaging (MRI) will be used to capture the detailed facial structure, micro-computational tomography (Micro-CT) to capture the underlying facial bone, MRI for detailed brain dimensions, and diffusion tensor imaging (DTI) for nerve fiber tracks in the fetal period. A novel computational program will be compiled to detect features specifically as function of alcohol exposure. The association and dissociation of facial and brain dysmorphology as a function of dose and timing of alcohol exposure will be analyzed to better inform the diagnosis of FAS/ FASD. These studies will be a collaboration sharing resources and methods and will be performed across both Basic and Clinical Science components in consortium effort. To date there is no cure for FAS/FASD, which is a life long ordeal from the birth. Experimental tests, using the above model and setting, of trophic peptides which have been known to prevent neurodegeneration in trials for Alzheimer Disease and protect cell death in embryonic stage, have been partially tested in the embryonic period to show protection against the alcohol-induced retardation. The new studies will test whether the trophic peptides can prevent alcohol-induced brain and facial dysmorphology as well as behavioral impairment known to occur in FAS.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AA017123-04
Application #
7905111
Study Section
Special Emphasis Panel (ZAA1-CC (11))
Program Officer
Dunty, Jr, William
Project Start
2007-09-30
Project End
2012-07-31
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
4
Fiscal Year
2010
Total Cost
$242,494
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Zhou, Feng C (2015) Dissecting FASD through the global transcriptome. Alcohol Clin Exp Res 39:408-12
Solzak, Jeffrey P; Liang, Yun; Zhou, Feng C et al. (2013) Commonality in Down and fetal alcohol syndromes. Birth Defects Res A Clin Mol Teratol 97:187-97
Shen, Li; Ai, Huisi; Liang, Yun et al. (2013) Effect of prenatal alcohol exposure on bony craniofacial development: a mouse MicroCT study. Alcohol 47:405-15
Hu, Jian-Guo; Wang, Xiao-Fei; Deng, Ling-Xiao et al. (2013) Cotransplantation of glial restricted precursor cells and Schwann cells promotes functional recovery after spinal cord injury. Cell Transplant 22:2219-36
Beversdorf, David Q; Nordgren, Richard E; Bonab, Ali A et al. (2012) 5-HT2 receptor distribution shown by [18F] setoperone PET in high-functioning autistic adults. J Neuropsychiatry Clin Neurosci 24:191-7
Zhou, Feng C; Bell, Richard L (2012) Editorial: Pharmacotherapies for the treatment of alcohol abuse and dependence. Recent Pat CNS Drug Discov 7:91-2
Zhou, Feng C; Chen, Yuanyuan; Love, Ada (2011) Cellular DNA methylation program during neurulation and its alteration by alcohol exposure. Birth Defects Res A Clin Mol Teratol 91:703-15
Anthony, Bruce; Vinci-Booher, Sophia; Wetherill, Leah et al. (2010) Alcohol-induced facial dysmorphology in C57BL/6 mouse models of fetal alcohol spectrum disorder. Alcohol 44:659-71
Fang, Shiaofen; Liu, Ying; Huang, Jeffrey et al. (2009) Facial Image Classification of Mouse Embryos for the Animal Model Study of Fetal Alcohol Syndrome. Proc Symp Appl Comput 2009:852-856
Zhou, Feng C; Fang, Yuan; Goodlett, Charles (2008) Peptidergic agonists of activity-dependent neurotrophic factor protect against prenatal alcohol-induced neural tube defects and serotonin neuron loss. Alcohol Clin Exp Res 32:1361-71